Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Structural Design, Synthesis, and Preliminary Biological Evaluation of Novel Dihomooxacalix[4]arene-Based Anti-tumor Agents.

An L, Wang C, Han L, Liu J, Huang T, Zheng Y, Yan C, Sun J.

Front Chem. 2019 Dec 13;7:856. doi: 10.3389/fchem.2019.00856. eCollection 2019.

2.

XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial.

Song Y, Yao C, Yao Y, Han H, Zhao X, Yu K, Liu L, Xu Y, Liu Z, Zhou Q, Wang Y, Ma Z, Zheng Y, Wu D, Tang Z, Zhang M, Pan S, Chai Y, Song Y, Zhang J, Pan L, Liu Y, Yu H, Yu X, Zhang H, Wang X, Du Z, Wan X, Tang Y, Tian Y, Zhu Y, Wang H, Yan X, Liu Z, Zhang B, Zhong N, Shang H, Bai C.

Crit Care Med. 2019 Sep;47(9):e735-e743. doi: 10.1097/CCM.0000000000003842.

3.

A reaction-based near-infrared fluorescent probe that can visualize endogenous selenocysteine in vivo in tumor-bearing mice.

Zhang L, Kai X, Zhang Y, Zheng Y, Xue Y, Yin X, Zhao J.

Analyst. 2018 Oct 8;143(20):4860-4869. doi: 10.1039/c8an00765a.

PMID:
30128454
4.

Structure-Based Drug Design of Small Molecule Peptide Deformylase Inhibitors to Treat Cancer.

Gao J, Wang T, Qiu S, Zhu Y, Liang L, Zheng Y.

Molecules. 2016 Mar 23;21(4):396. doi: 10.3390/molecules21040396.

5.

Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.

Liu Y, Zhang G, Li H, Han L, Fu A, Zhang N, Zheng Y.

Biomed Pharmacother. 2015 Oct;75:185-90. doi: 10.1016/j.biopha.2015.07.026. Epub 2015 Aug 31.

PMID:
26337230
6.

Effect of Avastin on the number and structure of tumor blood vessels of nude mice with A549 lung adenocarcinoma.

Zhang N, Zhang G, Zheng Y, Wang T, Wang H.

Exp Ther Med. 2014 Dec;8(6):1723-1726. Epub 2014 Sep 24.

7.

Theoretical study on the structural and antioxidant properties of some recently synthesised 2,4,5-trimethoxy chalcones.

Wang G, Xue Y, An L, Zheng Y, Dou Y, Zhang L, Liu Y.

Food Chem. 2015 Mar 15;171:89-97. doi: 10.1016/j.foodchem.2014.08.106. Epub 2014 Sep 4.

PMID:
25308647
8.

Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.

Han L, Zhang G, Zhang N, Li H, Liu Y, Fu A, Zheng Y.

Med Oncol. 2014 Sep;31(9):129. doi: 10.1007/s12032-014-0129-y. Epub 2014 Jul 27.

PMID:
25064732
9.

Density functional theory study of the structure-antioxidant activity of polyphenolic deoxybenzoins.

Xue Y, Zheng Y, An L, Dou Y, Liu Y.

Food Chem. 2014 May 15;151:198-206. doi: 10.1016/j.foodchem.2013.11.064. Epub 2013 Nov 20.

PMID:
24423521
10.

Theoretical study on the antioxidant properties of 2'-hydroxychalcones: H-atom vs. electron transfer mechanism.

Xue Y, Zheng Y, Zhang L, Wu W, Yu D, Liu Y.

J Mol Model. 2013 Sep;19(9):3851-62. doi: 10.1007/s00894-013-1921-x. Epub 2013 Jun 26.

PMID:
23801254
11.

Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A/B kinase inhibitors.

Zheng Y, Zheng M, Ling X, Liu Y, Xue Y, An L, Gu N, Ji M.

Bioorg Med Chem Lett. 2013 Jun 15;23(12):3523-30. doi: 10.1016/j.bmcl.2013.04.039. Epub 2013 Apr 25. Erratum in: Bioorg Med Chem Lett. 2013 Aug 1;23(15):4471. Jin, Min [corrected to Ji, Min].

PMID:
23664099
12.

L-citrulline protects against glycerol-induced acute renal failure in rats.

Liu Y, Fu X, Gou L, Li S, Lan N, Zheng Y, Yin X.

Ren Fail. 2013;35(3):367-73. doi: 10.3109/0886022X.2012.760408. Epub 2013 Jan 31.

PMID:
23362955
13.

Synthesis and quantum chemical studies of new 4-aminoquinazoline derivatives as Aurora A/B kinase inhibitors.

Zheng M, Zheng Y, Xue Y, Liu Y, An L, Zhang L, Ji M, Xue B, Wu X, Gong X, Gu N, Zhan X.

Chem Biol Drug Des. 2013 Mar;81(3):399-407. doi: 10.1111/cbdd.12089. Epub 2012 Dec 26.

PMID:
23279802
14.

Protective effects of nizofenone administration on the cognitive impairments induced by chronic restraint stress in mice.

Liu Y, Zhuang X, Gou L, Ling X, Tian X, Liu L, Zheng Y, Zhang L, Yin X.

Pharmacol Biochem Behav. 2013 Jan;103(3):474-80. doi: 10.1016/j.pbb.2012.09.009. Epub 2012 Sep 28.

PMID:
23026061
15.

Design, synthesis, and in vitro antitumor evaluation of novel phenylaminopyrimidine derivatives.

Zheng Y, Zheng M, Liu Y, Xue Y, Zhang L, An L, Liu L, Ji M.

Med Chem. 2013 May;9(3):340-50.

PMID:
22920155
16.

Design, synthesis, and in vitro antitumor activity evaluation of novel 4-pyrrylamino quinazoline derivatives.

Wu X, Li M, Tang W, Zheng Y, Lian J, Xu L, Ji M.

Chem Biol Drug Des. 2011 Dec;78(6):932-40. doi: 10.1111/j.1747-0285.2011.01234.x. Epub 2011 Oct 24.

17.

Design, synthesis of novel quinazolone alkaloids derivatives as potential antitumor agents.

Zheng Y, Sun M, Liu Y, Li M, Ji M.

Med Chem. 2011 Jul;7(4):295-300.

PMID:
21568876
18.

Design, synthesis, docking and antitumor activity of quinazolino [3, 4-a] thieno [3, 2-d] pyrimidin-8-one derivatives.

Zheng Y, Wu X, Xue B, Li M, Ji M.

Chem Biol Drug Des. 2010 Sep 1;76(3):285-90. doi: 10.1111/j.1747-0285.2010.01008.x. Epub 2010 Jun 29.

PMID:
20604799
19.

Design and synthesis of novel Gefitinib analogues with improved anti-tumor activity.

Wu X, Li M, Qu Y, Tang W, Zheng Y, Lian J, Ji M, Xu L.

Bioorg Med Chem. 2010 Jun 1;18(11):3812-22. doi: 10.1016/j.bmc.2010.04.046. Epub 2010 Apr 21.

20.

QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models.

Sun M, Zheng Y, Wei H, Chen J, Ji M.

J Enzyme Inhib Med Chem. 2009 Oct;24(5):1109-16. doi: 10.1080/14756360802632906.

PMID:
19555174

Supplemental Content

Loading ...
Support Center